Elanco Animal Health (ELAN) Gross Margin (2017 - 2026)

Elanco Animal Health has disclosed Gross Margin across 10 years of filings, most recently posting 58.33% for Q2 2026.

• In Q2 2026, Gross Margin rose 88.0% year-over-year to 58.33%; the TTM figure through Jun 2026 stood at 55.36% (up 63.0% YoY), while the FY2025 annual figure was 54.99%, up 12.0% from the prior year.
• Gross Margin came in at 58.33% for Q2 2026 at Elanco Animal Health, up from 57.26% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 60.7% in Q1 2023 to a low of 50.14% in Q4 2023.
• Average Gross Margin over 5 years is 55.77%, with a median of 57.26% recorded in 2024.
• Year-over-year, Gross Margin surged 402 bps in 2022 and tumbled 437 bps in 2023.
• Over 5 years, Gross Margin stood at 54.52% in 2022, then retreated by 8 bps to 50.14% in 2023, then gained by 1 bps to 50.88% in 2024, then rose by 1 bps to 51.49% in 2025, then advanced by 13 bps to 58.33% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 58.33% in Q2 2026, 57.26% in Q1 2026, and 51.49% in Q4 2025.